{"id":182,"date":"2021-10-09T11:31:32","date_gmt":"2021-10-09T11:31:32","guid":{"rendered":"http:\/\/eurosoi.org\/?p=182"},"modified":"2021-10-09T11:31:32","modified_gmt":"2021-10-09T11:31:32","slug":"%ef%bb%bfsample-data-were-acquired-in-an-lsr-fortessa-ii-bd-biosciences-circulation-cytometer-and-subsequently-analyzed-using-flowjo-software-tree-star","status":"publish","type":"post","link":"https:\/\/eurosoi.org\/?p=182","title":{"rendered":"\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star)"},"content":{"rendered":"

\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star). For a more complex visualization of the flow cytometry data for memory and naive T cell populations, we used value of <0.05 was considered significant. ACKNOWLEDGMENTS This study was supported by NIH, National Institute of Allergy and Infectious Diseases, grants R21-AI131763 and U01-AI35041. We thank Lisa Borghesi for her help in using the tSNE analysis software in FlowJo. CD8+ T cells into effector T cells expressing high levels of T-box transcription factor (T-bethi) and eomesodermin (Eomes+). In contrast, PD-1 blockade enhanced the overall magnitude of memory HIV-specific CTL responses and reversed the worn out memory phenotype from a T-betlow\/Eomes+ to a T-bethi\/Eomes+ phenotype. These results indicate that this PD-L1\/PD-1 signaling pathway has a previously unappreciated dual role in the induction and regulation P005672 HCl (Sarecycline HCl) of HIV-1-specific CTL immunity, which is usually greatly determined by the context and differentiation stage of the responsive CD8+ T cells. IMPORTANCE Targeting the PD-1\/PD-L1 immune checkpoint axis with signaling inhibitors has proven to be a powerful immunotherapeutic strategy to enhance the functional quality P005672 HCl (Sarecycline HCl)<\/a> and survival of existing antigen-specific effector T cells. However, our study demonstrates that this context and timing of PD-1 signaling in T cells greatly impact the outcome of the effector response. In particular, we show that PD-1 activation plays a positive role during the DC-mediated initiation stage of the primary T cell response, while it serves as an Mouse monoclonal to BNP<\/a> inhibitory mechanism during the effector phase of the response. Therefore, caution should be taken in the design of therapies that include targeting of the PD-1\/PD-L1 signaling pathway in order to avoid potential unfavorable impacts around the induction of T cell responses. (18, 19) and in the nonhuman primate simian immunodeficiency computer virus model (24). Although PD-1\/PD-L1 signaling inhibition appears to have beneficial effects in reversing T cell exhaustion in several contexts of malignancy and chronic infections, PD-1\/PD-L1 signaling is also required for proper development of main Th1 responses against intracellular bacteria (25,C28). Interestingly, we demonstrated that this PD-1 blockade experienced opposing effects on CTL function when implemented during main versus secondary activation in the setting of human papillomavirus (29). However, whether PD-1 has any role in the priming and differentiation of naive T cells into effector CD8+ T cells or whether PD-1 blockade has a differential impact on naive versus memory CD8+ T cell responses remains unclear. Recent findings from our group spotlight the use of antigen-presenting dendritic cells (DC) to induce main CD8+ CTL responses from naive T cell precursors, rather than merely recalling memory T cells, to effectively target P005672 HCl (Sarecycline HCl) and kill HIV-1-infected cells during chronic HIV-1 contamination (30). Therefore, in this study we evaluated the role of the PD-1 pathway in DC-induced main and memory T cell responses in chronic HIV-1 contamination. RESULTS Type 1 polarized DC (MDC1) stimulated with CD40L primary naive CD8+ T cell responses to natural HIV-1 Gag 9-mers. MDC1 are known to be effective drivers of Th1-skewed cell-mediated T cell responses in part because of their ability to secrete copious amounts of IL-12p70 upon CD40L activation (31, 32). This unique house of MDC1 supports their potential as an immunotherapy for HIV-1 contamination (33, 34). To demonstrate the importance of this T helper transmission, we evaluated the ability of MDC1 to induce main HIV-1 Gag-specific T cell responses in the presence or absence CD40L. HIV-1 peptide-loaded MDC1 were generated from HLA-A2+ HIV-1-seronegative donors, harvested, and cocultured with autologous CD8+ T cells in the presence or absence of gamma-irradiated CD40L-expressing J558 cells (J558-CD40L) (35). It is important to note that this parental murine cell collection J558 does not produce factors that activate human DC production of cytokines or activate T cells (36). Because of this, these CD40L transfected cells have been routinely used as a standard surrogate for Th cell CD40L help in numerous DC-mediated T cell activation studies (31, 32, 35) and as a quality assurance monitoring tool for DC clinical trials (37). After 12?days of stimulation, CD8+ T cells were then restimulated with gamma-irradiated, Gag peptide-loaded, HLA-A2+ T2 cells. At day 21 postpriming, the T cells were tested for production of IFN- in response to the relevant peptide antigens by IFN- enzyme-linked immunospot (ELISPOT) assay. We observed that MDC1 were unable to generate strong HIV-1 Gag-specific IFN- responses to any of the five peptides utilized for priming (Fig. 1A, top wells, and Fig. 1B, black symbols) when cultures were initiated in the absence of J558-CD40L. In contrast, when J558-CD40L was present at the initiation of the MDC1-T cell coculture, long-term HIV-1 Gag-specific IFN- responses were generated against 2 out of 5 peptides in the first P005672 HCl (Sarecycline HCl) donor tested.<\/p>\n","protected":false},"excerpt":{"rendered":"

\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star). For a more complex visualization of the flow cytometry data for memory and naive T cell populations, we used value of<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-182","post","type-post","status-publish","format-standard","hentry","category-lysophosphatidic-acid-receptors"],"yoast_head":"\n\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star) - JAK2 inhibitor against human prostate cancer cells<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eurosoi.org\/?p=182\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star) - JAK2 inhibitor against human prostate cancer cells\" \/>\n<meta property=\"og:description\" content=\"\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star). For a more complex visualization of the flow cytometry data for memory and naive T cell populations, we used value of\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eurosoi.org\/?p=182\" \/>\n<meta property=\"og:site_name\" content=\"JAK2 inhibitor against human prostate cancer cells\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-09T11:31:32+00:00\" \/>\n<meta name=\"author\" content=\"info\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"info\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=182#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=182\"},\"author\":{\"name\":\"info\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#\\\/schema\\\/person\\\/ba68ae543ef2903c0b995cd8992cedfd\"},\"headline\":\"\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star)\",\"datePublished\":\"2021-10-09T11:31:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=182\"},\"wordCount\":63,\"articleSection\":[\"Lysophosphatidic Acid Receptors\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=182\",\"url\":\"https:\\\/\\\/eurosoi.org\\\/?p=182\",\"name\":\"\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star) - JAK2 inhibitor against human prostate cancer cells\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#website\"},\"datePublished\":\"2021-10-09T11:31:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#\\\/schema\\\/person\\\/ba68ae543ef2903c0b995cd8992cedfd\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=182#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eurosoi.org\\\/?p=182\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/?p=182#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eurosoi.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#website\",\"url\":\"https:\\\/\\\/eurosoi.org\\\/\",\"name\":\"JAK2 inhibitor against human prostate cancer cells\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eurosoi.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eurosoi.org\\\/#\\\/schema\\\/person\\\/ba68ae543ef2903c0b995cd8992cedfd\",\"name\":\"info\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g\",\"caption\":\"info\"},\"sameAs\":[\"http:\\\/\\\/eurosoi.org\"],\"url\":\"https:\\\/\\\/eurosoi.org\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star) - JAK2 inhibitor against human prostate cancer cells","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eurosoi.org\/?p=182","og_locale":"en_US","og_type":"article","og_title":"\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star) - JAK2 inhibitor against human prostate cancer cells","og_description":"\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star). For a more complex visualization of the flow cytometry data for memory and naive T cell populations, we used value of","og_url":"https:\/\/eurosoi.org\/?p=182","og_site_name":"JAK2 inhibitor against human prostate cancer cells","article_published_time":"2021-10-09T11:31:32+00:00","author":"info","twitter_card":"summary_large_image","twitter_misc":{"Written by":"info"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eurosoi.org\/?p=182#article","isPartOf":{"@id":"https:\/\/eurosoi.org\/?p=182"},"author":{"name":"info","@id":"https:\/\/eurosoi.org\/#\/schema\/person\/ba68ae543ef2903c0b995cd8992cedfd"},"headline":"\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star)","datePublished":"2021-10-09T11:31:32+00:00","mainEntityOfPage":{"@id":"https:\/\/eurosoi.org\/?p=182"},"wordCount":63,"articleSection":["Lysophosphatidic Acid Receptors"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/eurosoi.org\/?p=182","url":"https:\/\/eurosoi.org\/?p=182","name":"\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star) - JAK2 inhibitor against human prostate cancer cells","isPartOf":{"@id":"https:\/\/eurosoi.org\/#website"},"datePublished":"2021-10-09T11:31:32+00:00","author":{"@id":"https:\/\/eurosoi.org\/#\/schema\/person\/ba68ae543ef2903c0b995cd8992cedfd"},"breadcrumb":{"@id":"https:\/\/eurosoi.org\/?p=182#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eurosoi.org\/?p=182"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/eurosoi.org\/?p=182#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eurosoi.org\/"},{"@type":"ListItem","position":2,"name":"\ufeffSample data were acquired in an LSR Fortessa II (BD Biosciences) circulation cytometer and subsequently analyzed using FlowJo software (Tree Star)"}]},{"@type":"WebSite","@id":"https:\/\/eurosoi.org\/#website","url":"https:\/\/eurosoi.org\/","name":"JAK2 inhibitor against human prostate cancer cells","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eurosoi.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/eurosoi.org\/#\/schema\/person\/ba68ae543ef2903c0b995cd8992cedfd","name":"info","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/deee51ad824afccf8f584928d162e0fea08029f81b2d40a83307df75388ac916?s=96&d=mm&r=g","caption":"info"},"sameAs":["http:\/\/eurosoi.org"],"url":"https:\/\/eurosoi.org\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts\/182","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=182"}],"version-history":[{"count":1,"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts\/182\/revisions"}],"predecessor-version":[{"id":183,"href":"https:\/\/eurosoi.org\/index.php?rest_route=\/wp\/v2\/posts\/182\/revisions\/183"}],"wp:attachment":[{"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=182"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=182"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eurosoi.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=182"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}